Information, deadlines and resource documents for U.S. tariff actions and the responses by the rest of the world.
Internationally recognized trade compliance training.
Subscribe to daily updates
The Justice Department’s Drug Enforcement Administration has issued a notice proposing the 2017 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act as well as an assessment of annual needs for the List I chemicals ephedrine, pseudoephedrine and phenylpropanolamine. These amounts represent those quantities of the covered substances to be manufactured in the U.S. to provide for the estimated medical, scientific, research and industrial needs of the U.S., lawful export requirements, and the establishment and maintenance of reserve stocks. These quotas include imports of ephedrine, pseudoephedrine and phenylpropanolamine but do not include imports of controlled substances for use in industrial processes. Comments on this proposal are due no later than Aug. 22.
Separately, the DEA is also accepting comments through Aug. 22 on its proposal to establish aggregate production quotas for 2016 for two temporarily schedule substances and to adjust the 2016 aggregate production quotas and assessment of annual needs for several schedule I and II controlled substances as well as ephedrine, pseudoephedrine and phenylpropanolamine.
September 29, 2020 // Trade Report
September 28, 2020 // Trade Report
September 21, 2020 // Trade Report
September 10, 2020 // Trade Report